Iranian Company Makes ‘Coageight’ Drug for Hemophilia Patients

TEHRAN (ANA)- A knowledge-based company in Iran has succeeded in producing ‘Coageight’ drug which contains the active substance efmoroctocog alfa, a recombinant coagulation factor VIII, Fc fusion protein for hemophilia patients. Source: ANA